Multi-Fidelity Gaussian Processes for Translational Modelling of Clinical Outcomes

Bridging the gap between animal and human experiments remains a major challenge in translational medicine, particularly in early drug development. Progress is constrained by financial cost, the difficulty of integrating heterogeneous in vitro and in vivo data, and the desire to reduce the use of ani